glp 1 injection vs oral vs. injectable GLP-1s explained (pill, shot, or the brand new one?) obesitymedicine #medicare #glp1 #patientaccess Size:120 Weight Management

glp 1 injection vs oral vs. injectable GLP-1s explained (pill, shot, or the brand new one?) obesitymedicine #medicare #glp1 #patientaccess Size:120 Weight Management

obesitymedicine #medicare #glp1 #patientaccess #priorauthorization | Joseph Zucchi, PA-C, MPAS | 34 comments

Potential advantages include: Improved employee satisfaction Stronger recruiting and retention Better management of obesity-related conditions Competitive employee benefits Support for long-term employee wellness However, comprehensive coverage also creates the highest pharmacy cost exposure

Weight Management

Size:120

Obesity Drug Market Overview and Growth Potential The US obesity drug market is on a meteoric rise, projected to soar past USD 73 billion by 2034